Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications

被引:173
|
作者
Wang, Wei [1 ,2 ]
Nag, Subhasree [1 ]
Zhang, Xu [1 ]
Wang, Ming-Hai [2 ,3 ]
Wang, Hui [4 ]
Zhou, Jianwei [5 ]
Zhang, Ruiwen [1 ,2 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX 79106 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX 79106 USA
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
[5] Nanjing Med Univ, Sch Publ Hlth, Ctr Canc, Dept Mol Cell Biol & Toxicol, Nanjing 210029, Jiangsu, Peoples R China
关键词
ribosomal protein; RP-MDM2-p53; pathway; ribosomopathy; cancer; drug discovery; DIAMOND-BLACKFAN ANEMIA; GASTRIC-CANCER CELLS; RNA-POLYMERASE-I; NF-KAPPA-B; TUMOR-SUPPRESSOR P53; MEMBRANE-BOUND RIBOSOMES; ZINC-FINGER DOMAIN; C-MYC ACTIVITY; FACTOR TTF-I; MESSENGER-RNA;
D O I
10.1002/med.21327
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ribosomes are essential components of the protein synthesis machinery. The process of ribosome biogenesis is well organized and tightly regulated. Recent studies have shown that ribosomal proteins (RPs) have extraribosomal functions that are involved in cell proliferation, differentiation, apoptosis, DNA repair, and other cellular processes. The dysfunction of RPs has been linked to the development and progression of hematological, metabolic, and cardiovascular diseases and cancer. Perturbation of ribosome biogenesis results in ribosomal stress, which triggers activation of the p53 signaling pathway through RPs-MDM2 interactions, resulting in p53-dependent cell cycle arrest and apoptosis. RPs also regulate cellular functions through p53-independent mechanisms. We herein review the recent advances in several forefronts of RP research, including the understanding of their biological features and roles in regulating cellular functions, maintaining cell homeostasis, and their involvement in the pathogenesis of human diseases. We also highlight the translational potential of this research for the identification of molecular biomarkers, and in the discovery and development of novel treatments for human diseases.
引用
收藏
页码:225 / 285
页数:61
相关论文
共 50 条
  • [41] Tumor microenvironment and drug resistance in lung adenocarcinoma: molecular mechanisms, prognostic implications, and therapeutic strategies
    Cao, Qianqian
    Li, Chenxuan
    Li, Ying
    Kong, Xiangjing
    Wang, Shoushi
    Ma, Jun
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [42] Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
    Zhong, Qian
    Xiao, Xina
    Qiu, Yijie
    Xu, Zhiqiang
    Chen, Chunyu
    Chong, Baochen
    Zhao, Xinjun
    Hai, Shan
    Li, Shuangqing
    An, Zhenmei
    Dai, Lunzhi
    MEDCOMM, 2023, 4 (03):
  • [43] STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications
    Babaei, Ghader
    Sadraei, Samin
    Yarahmadi, Maral
    Omidvari, Samareh
    Aarabi, Aryan
    Rajabibazl, Masoumeh
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [44] Roles of lncRNAs in NF-κB-Mediated Macrophage Inflammation and Their Implications in the Pathogenesis of Human Diseases
    Shin, Jae-Joon
    Park, Jeongkwang
    Shin, Hyeung-Seob
    Arab, Imene
    Suk, Kyoungho
    Lee, Won-Ha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [45] The roles of moonlight ribosomal proteins in the development of human cancers
    Molavi, Ghader
    Samadi, Nasser
    Hosseingholi, Elaheh Zadeh
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 8327 - 8341
  • [46] Bone metastasis: pathogenesis and therapeutic implications
    Clezardin, Philippe
    Teti, Anna
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (08) : 599 - 608
  • [47] Bone metastasis: pathogenesis and therapeutic implications
    Philippe Clezardin
    Anna Teti
    Clinical & Experimental Metastasis, 2007, 24 : 599 - 608
  • [48] INHIBITION OF THE COMPLEMENT SYSTEM BY GLUTATHIONE: MOLECULAR MECHANISMS AND POTENTIAL THERAPEUTIC IMPLICATIONS
    Perricone, C.
    De Carolis, C.
    Giacomelli, R.
    Greco, E.
    Cipriani, P.
    Ballanti, E.
    Novelli, L.
    Perricone, R.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (01) : 63 - 68
  • [49] LINC01503 in cancer: from molecular mechanisms to therapeutic implications
    Shuai, You
    Qian, Haili
    Yuan, Peng
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [50] Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications
    Lu, Jia
    Chen, Siwei
    Bai, Xuejiao
    Liao, Minru
    Qiu, Yuling
    Zheng, Ling-Li
    Yu, Haiyang
    BIOCHEMICAL PHARMACOLOGY, 2023, 218